Chemerin levels as predictor of acute coronary events: A case-control study nested within the veterans affairs normative aging study

Metabolism: Clinical and Experimental

Volumn 63, Issue 6, 2014, Pages 760-766

  Aronis, Konstantinos N ^a,b   Sahin Efe, Ayse ^a   Chamberland, John P ^a   Spiro III, Avron ^c   Vokonas, Pantel ^b   Mantzoros, Christos S ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY   (United States)

Author keywords

Acute Coronary Events; Chemerin; Normative Aging Study

Indexed keywords

ADIPONECTIN; CHEMERIN; LEPTIN;

ACUTE CORONARY SYNDROME; ADULT; AGE; AGED; ARTICLE; BLOOD SAMPLING; BODY HEIGHT; BODY MASS; BODY WEIGHT; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; SMOKING; WAIST HIP RATIO;

ACUTE CORONARY EVENTS; CHEMERIN; NORMATIVE AGING STUDY;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; UNITED STATES; VETERANS;

EID: 84901228269     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2014.02.013     Document Type: Article

References (52)

1. W. Meder, M. Wendland, and A. Busmann et al. Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23 FEBS Lett 555 2003 495 499
2. M.C. Ernst, and C.J. Sinal Chemerin: at the crossroads of inflammation and obesity Trends Endocrinol Metab 21 2010 660 667
3. V. Wittamer, J.D. Franssen, and M. Vulcano et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids J Exp Med 198 2003 977 985
4. V. Wittamer, B. Bondue, and A. Guillabert et al. Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity J Immunol 175 2005 487 493
5. S. Nagpal, S. Patel, and H. Jacobe et al. Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin J Invest Dermatol 109 1997 91 95
6. S.A. Polyzos, J. Kountouras, and A.D. Anastasilakis et al. Irisin in patients with nonalcoholic fatty liver disease Metabolism 63 2014 207 217
7. J.P. Chamberland, R.L. Berman, and K.N. Aronis et al. Chemerin is expressed mainly in pancreas and liver, is regulated by energy deprivation, and lacks day/night variation in humans Eur J Endocrinol 169 2013 453 462
8. K. Bozaoglu, J.E. Curran, and C.J. Stocker et al. Chemerin, a novel adipokine in the regulation of angiogenesis J Clin Endocrinol Metab 95 2010 2476 2485
9. J. Kaur, R. Adya, and B.K. Tan et al. Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis Biochem Biophys Res Commun 391 2010 1762 1768
10. K.B. Goralski, T.C. McCarthy, and E.A. Hanniman et al. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism J Biol Chem 282 2007 28175 28188
11. S.G. Roh, S.H. Song, and K.C. Choi et al. Chemerin - a new adipokine that modulates adipogenesis via its own receptor Biochem Biophys Res Commun 362 2007 1013 1018
12. K. Bozaoglu, K. Bolton, and J. McMillan et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome Endocrinology 148 2007 4687 4694
13. M. Takahashi, Y. Takahashi, and K. Takahashi et al. Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3 T3-L1 adipocytes FEBS Lett 582 2008 573 578
14. K. Mussig, H. Staiger, and F. Machicao et al. RARRES2, encoding the novel adipokine chemerin, is a genetic determinant of disproportionate regional body fat distribution: a comparative magnetic resonance imaging study Metabolism 58 2009 519 524
15. S.I. Syed Ikmal, H. Zaman Huri, and S.R. Vethakkan et al. Potential biomarkers of insulin resistance and atherosclerosis in type 2 diabetes mellitus patients with coronary artery disease Int J Endocrinol 2013 2013 698567
16. I. Jialal, S. Devaraj, and H. Kaur et al. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome J Clin Endocrinol Metab 98 2013 E514 E517
17. E.C. Guzel, C. Celik, and R. Abali et al. Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome Gynecol Endocrinol 2014 10.3109/09513590.2014.888412 [Epub ahead of print]
18. D. Wang, G.Y. Yuan, and X.Z. Wang et al. Plasma chemerin level in metabolic syndrome Genet Mol Res 12 2013 5986 5991
19. K. Bozaoglu, D. Segal, and K.A. Shields et al. Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population J Clin Endocrinol Metab 94 2009 3085 3088
20. J. Weigert, M. Neumeier, and J. Wanninger et al. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes Clin Endocrinol (Oxf) 72 2010 342 348
21. H. Sell, A. Divoux, and C. Poitou et al. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery J Clin Endocrinol Metab 95 2010 2892 2896
22. A. Tonjes, M. Fasshauer, and J. Kratzsch et al. Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes PLoS One 9 1-6 2010 e13911 10.1371/journal.pone.0013911
23. H.Y. Chen, C.C. Lin, and Y.L. Chiu et al. Serum fetuin a and chemerin levels correlate with hepatic steatosis and regional adiposity in maintenance hemodialysis patients PLoS One 7 1-9 2012 e38514 10.1371/journal.pone.0038415
24. A.A. Roman, S.D. Parlee, and C.J. Sinal Chemerin: a potential endocrine link between obesity and type 2 diabetes Endocrine 42 2012 243 251
25. P. Gu, W. Jiang, and B. Lu et al. Chemerin is associated with inflammatory markers and metabolic syndrome phenotypes in hypertension patients Clin Exp Hypertens 2013 10.3109/10641963.2013.827697 [Epub ahead of print]
26. S. Docke, J.F. Lock, and A.L. Birkenfeld et al. Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease Eur J Endocrinol 169 2013 547 557
27. A.R. Aroor, S. McKarns, and V.G. Demarco et al. Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance Metabolism 62 2013 1543 1552
28. B.J. Kwon, D.W. Kim, and S.H. Her et al. Metabolically obese status with normal weight is associated with both the prevalence and severity of angiographic coronary artery disease Metabolism 62 2013 952 960
29. R. Chakaroun, M. Raschpichler, and N. Kloting et al. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity Metabolism 61 2012 706 714
30. X. Terra, T. Auguet, and E. Guiu-Jurado et al. Long-term changes in leptin, chemerin and ghrelin levels following different bariatric surgery procedures: Roux-en-Y gastric bypass and sleeve gastrectomy Obes Surg 23 2013 1790 1798
31. S.A. Polyzos, J. Kountouras, and A.D. Anastasilakis et al. Irisin in patients with nonalcoholic fatty liver disease Metabolism 63 2 2014 207 217
32. S.G. Spiroglou, C.G. Kostopoulos, and J.N. Varakis et al. Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis J Atheroscler Thromb 17 2010 115 130
33. H.J. Yoo, H.Y. Choi, and S.J. Yang et al. Circulating chemerin level is independently correlated with arterial stiffness J Atheroscler Thromb 19 2012 59 68
34. M. Lehrke, A. Becker, and M. Greif et al. Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis Eur J Endocrinol 161 2009 339 344
35. Q. Yan, Y. Zhang, and J. Hong et al. The association of serum chemerin level with risk of coronary artery disease in Chinese adults Endocrine 41 2011 281 288
36. B. Dong, W. Ji, and Y. Zhang Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome Intern Med 50 2011 1093 1097
37. X. Gao, S. Mi, and F. Zhang et al. Association of chemerin mRNA expression in human epicardial adipose tissue with coronary atherosclerosis Cardiovasc Diabetol 10 2011 87
38. B. Bell, C.L. Rose, and A. Damon The Veterans Administration longitudinal study of healthy aging Gerontologist 6 1966 179 184
39. A. Sahin-Efe, F. Katsikeris, and C.S. Mantzoros Advances in adipokines Metabolism 61 2012 1659 1665
40. B.J. Ko, K.H. Park, and C.S. Mantzoros Diet patterns, adipokines, and metabolism: where are we and what is next? Metabolism 63 2014 168 177
41. H.O. El-Mesallamy, D.H. Kassem, and E. El-Demerdash et al. Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus Metabolism 60 2011 63 70
42. J. Van de Voorde, B. Pauwels, and C. Boydens et al. Adipocytokines in relation to cardiovascular disease Metabolism 62 2013 1513 1521
43. Q. Li, Y. Lu, and L. Sun et al. Plasma adiponectin levels in relation to prognosis in patients with angiographic coronary artery disease Metabolism 2012 1803-1808 61
44. D. Giannessi, C. Caselli, and S. Del Ry et al. Adiponectin is associated with abnormal lipid profile and coronary microvascular dysfunction in patients with dilated cardiomyopathy without overt heart failure Metabolism 60 2011 227 233
45. A. Hirata, K. Kishida, and H. Nakatsuji et al. High serum C1q-adiponectin/total adiponectin ratio correlates with coronary artery disease in Japanese type 2 diabetics Metabolism 62 2013 578 585
46. K. Piestrzeniewicz, K. Luczak, and J. Komorowski et al. Resistin increases with obesity and atherosclerotic risk factors in patients with myocardial infarction Metabolism 57 2008 488 493
47. L. Xiaotao, Z. Xiaoxia, and X. Yue et al. Serum chemerin levels are associated with the presence and extent of coronary artery disease Coron Artery Dis 23 2012 412 416
48. X. Lin, X. Tang, and Q. Jiang et al. Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with type 2 diabetes Clin Lab 58 2012 539 544
49. Y.J. Hah, N.K. Kim, and M.K. Kim et al. Relationship between chemerin levels and cardiometabolic parameters and degree of coronary stenosis in Korean patients with coronary artery disease Diabetes Metab J 35 2011 248 254
50. M. Becker, K. Rabe, and C. Lebherz et al. Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on high-fat diet Diabetes 59 2010 2898 2903
51. P. Gisondi, V. Lora, and C. Bonauguri et al. Serum chemerin is increased in patients with chronic plaque psoriasis and normalizes following treatment with infliximab Br J Dermatol 168 2013 749 755
52. S.H. Kim, S.H. Lee, and K.Y. Ahn et al. Effect of lifestyle modification on serum chemerin concentration and its association with insulin sensitivity in overweight and obese adults with type 2 diabetes Clin Endocrinol (Oxf) 2013 10.1111/cen.12249